Discover the Clinical Performance Results of Aiosyn Mitosis Breast at ECDP 2024
admin@pathologynews.com2024-06-04T08:45:10+00:00Aiosyn, a medical software company specializing in AI-powered pathology solutions for cancer and kidney diseases, recently conducted a clinical performance study in collaboration with Radboud university medical center. This study evaluated the benefits of Aiosyn Mitosis Breast for mitotic figure detection in clinical settings. Following the presentation at the USCAP 113th Annual Meeting, these results will be showcased at the 20th European Congress on Digital Pathology.










